Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Other Working Capital Changes (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Other Working Capital Changes for 16 consecutive years, with -$368000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 78.17% to -$368000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$250000.0, a 89.89% increase, with the full-year FY2024 number at -$702000.0, up 57.48% from a year prior.
  • Other Working Capital Changes was -$368000.0 for Q3 2025 at Harvard Bioscience, down from $44000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.7 million in Q2 2021 to a low of -$1.7 million in Q3 2024.
  • A 5-year average of -$147842.1 and a median of -$97000.0 in 2025 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 1095.18% in 2021, then tumbled 192.69% in 2023.
  • Harvard Bioscience's Other Working Capital Changes stood at -$1.6 million in 2021, then rose by 22.07% to -$1.3 million in 2022, then decreased by 24.59% to -$1.6 million in 2023, then skyrocketed by 110.68% to $171000.0 in 2024, then tumbled by 315.2% to -$368000.0 in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Other Working Capital Changes are -$368000.0 (Q3 2025), $44000.0 (Q2 2025), and -$97000.0 (Q1 2025).